Le Lézard
Classified in: Health
Subjects: DIS, DEI

CORE IQ'S NEW PODCAST POST-TRAUMATIC THRIVING HOSTS GERI JEWELL, 'FACTS OF LIFE' AND 'DEADWOOD' STAR AND FIRST DISABLED PERSON CAST ON PRIME-TIME TV.


Geri Jewell was born into trauma.  Born at three pounds, she was the smallest premature baby and later diagnosed with cerebral palsy.  Her mother treated Geri as "as one of the bunch."

LAGUNA BEACH, Calif., May 16, 2022 /PRNewswire/ -- Born into TraumaGeri Jewell is best known as Cousin Geri on the NBC's sitcom, The Facts of Life and HBO's Deadwood. She began doing standup at the Comedy Store in 1978. 

https://vimeo.com/manage/videos/710441227

Dr. Randall Bell and Tanya Brown explore Geri's childhood and growing up disabled. They discuss how she was bullied by the neighborhood's kids and even some parents. She talks about sexual abuse, high school, navigating Hollywood's Sunset Boulevard and landing on The Facts of Life.  Geri kept her incredible sense of humor through it all.

Post-Traumatic Thriving is a podcast that addresses the toughest issues around trauma and recovery. Unresolved trauma is the #1 problem facing humanity, with 66% to 85% of all college-age people having experienced at least one traumatic event.

Unresolved trauma fuels self-medication, depression, and violent crime. Unprocessed, trauma can lead to suicide, the leading cause of death in the United States according to the National Institute of Mental Health. This podcast takes on the issues by:

Dr. Bell is a sociologist and economist who specializes in disaster recovery projects. "We can tap into trauma and make it the fuel to thrive," says Dr. Randall Bell, and the author of the bestselling book, Post-Traumatic Thriving.  

Ms. Tanya Brown, MA is the author of Finding Peace Amid the Chaos. The 1994 death of Tanya's sister Nicole Brown Simpson generated a media frenzy around O.J. Simpson. Today, she is a celebrity author, and a motivational speaker and life coach. When facing trauma Tanya said, "You need to ask for help."

Core IQ https://www.coreiq.com/ is a non-profit organization that produces the podcast.

Available on multiple podcast platforms.

Links:
https://www.tiktok.com/@posttraumaticthrivingpod
https://www.youtube.com/channel/UC8ZeUuGqzsYdJmhr2JHD2ag
https://www.instagram.com/coreiq/
https://www.facebook.com/coreiqskills
https://www.linkedin.com/company/coreiqinc/about/?viewAsMember=true
https://twitter.com/coreiq

Mel Levy [email protected] 949-497-7600 ext. 14

Reviews, photos, and interview requests available upon request.

 

SOURCE Core IQ, Inc.


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: